• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients.

作者信息

Hiraoka Atsushi, Ohama Hideko, Tada Fujimasa, Fukunishi Yoshiko, Yanagihara Emi, Kato Kanako, Kato Masaya, Saneto Hironobu, Izumoto Hirofumi, Ueki Hidetaro, Yoshino Takeaki, Kitahata Shogo, Kawamura Tomoe, Kuroda Taira, Suga Yoshifumi, Miyata Hideki, Hirooka Masashi, Abe Masanori, Matsuura Bunzo, Ninomiya Tomoyuki, Hiasa Yoichi

机构信息

Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.

Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan.

出版信息

J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1906-1911. doi: 10.1002/jcsm.13268. Epub 2023 May 19.

DOI:10.1002/jcsm.13268
PMID:37203385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10401522/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb14/10401522/a94e07837f4a/JCSM-14-1906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb14/10401522/a94e07837f4a/JCSM-14-1906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb14/10401522/a94e07837f4a/JCSM-14-1906-g001.jpg

相似文献

1
Simple method for predicting muscle volume loss using geriatric nutritional risk index in hepatocellular carcinoma patients.利用老年营养风险指数预测肝细胞癌患者肌肉量丢失的简单方法。
J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1906-1911. doi: 10.1002/jcsm.13268. Epub 2023 May 19.
2
Nutritional diagnosis of patients with hepatocellular carcinoma: what is the best method?肝细胞癌患者的营养诊断：最佳方法是什么？
Nutr Hosp. 2019 Aug 26;36(4):884-889. doi: 10.20960/nh.02542.
3
A man with hepatocellular carcinoma presenting as erythroderma.一名以红皮病为表现的肝细胞癌男性患者。
Dig Liver Dis. 2011 Dec;43(12):e28. doi: 10.1016/j.dld.2011.05.019. Epub 2011 Jul 5.
4
Liver invasion of the duodenum due to hepatocellular carcinoma.肝细胞癌导致十二指肠肝侵犯。
Clin Gastroenterol Hepatol. 2012 May;10(5):A25. doi: 10.1016/j.cgh.2011.12.035. Epub 2012 Jan 8.
5
Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC).营养不良是肝细胞癌（HCC）患者的预后因素。
Clin Nutr. 2015 Dec;34(6):1122-7. doi: 10.1016/j.clnu.2014.11.007. Epub 2014 Nov 18.
6
Hepatocellular carcinoma in mixed cryoglobulinemia patients.混合性冷球蛋白血症患者的肝细胞癌
Clin Exp Rheumatol. 1996 Jan-Feb;14(1):111-2.
7
Acquired hemophilia A in a patient with hepatocellular carcinoma: a case report and literature review.一名肝细胞癌患者获得性甲型血友病：病例报告及文献综述
Ann Hematol. 2016 Dec;95(12):2099-2100. doi: 10.1007/s00277-016-2825-5. Epub 2016 Sep 26.
8
Erythrocytosis in a patient with hepatocellular carcinoma.一名肝细胞癌患者的红细胞增多症。
J Clin Gastroenterol. 2002 Oct;35(4):365-6. doi: 10.1097/00004836-200210000-00022.
9
Relationships between blood levels of fat soluble vitamins and disease etiology and severity in adults awaiting liver transplantation.成人等待肝移植时，脂溶性维生素血水平与疾病病因和严重程度的关系。
J Gastroenterol Hepatol. 2011 Sep;26(9):1402-10. doi: 10.1111/j.1440-1746.2011.06746.x.
10
Image of the month. Synchronous hepatocellular carcinoma and metastatic squamous cell carcinoma with life-threatening hypercalcemia.本月病例影像。同时性肝细胞癌和转移性鳞状细胞癌伴危及生命的高钙血症。
Clin Gastroenterol Hepatol. 2010 Feb;8(2):A24. doi: 10.1016/j.cgh.2009.04.006. Epub 2009 Apr 16.

引用本文的文献

1
Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma.老年营养风险指数作为不可切除肝细胞癌患者接受度伐利尤单抗联合曲美木单抗治疗期间免疫介导不良事件风险因素的潜在作用。
J Gastroenterol. 2025 Aug 20. doi: 10.1007/s00535-025-02290-4.
2
Predictive value of geriatric nutritional risk indexes for hospital readmission and mortality in older patients.老年营养风险指数对老年患者再次入院和死亡率的预测价值
Aging Clin Exp Res. 2024 Dec 27;37(1):15. doi: 10.1007/s40520-024-02899-0.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study.

本文引用的文献

1
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.阿替利珠单抗联合贝伐单抗治疗与不可切除肝细胞癌患者肌肉量减少的关系：多中心分析
Liver Cancer. 2022 Dec 8;12(3):209-217. doi: 10.1159/000527402. eCollection 2023 Aug.
2
Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.肌少症对接受免疫检查点抑制剂治疗的恶性肿瘤临床结局的预后影响：一项系统评价和荟萃分析
Front Oncol. 2021 Aug 26;11:726257. doi: 10.3389/fonc.2021.726257. eCollection 2021.
3
代谢功能障碍相关脂肪性肝病及酒精摄入增加的代谢功能障碍相关脂肪性肝病会增加肝细胞癌和新发或失代偿期肝硬化的发生风险：一项韩国全国性研究
Liver Cancer. 2023 Dec 22;13(4):426-437. doi: 10.1159/000535943. eCollection 2024 Aug.
4
A Low Geriatric Nutritional Risk Index Is Associated with Low Muscle Volume and a Poor Prognosis among Cirrhotic Patients.低老年营养风险指数与肝硬化患者的低肌肉量和不良预后相关。
Medicina (Kaunas). 2023 Nov 29;59(12):2099. doi: 10.3390/medicina59122099.
Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.
利用指圈（yubi-wakka）测试轻松监测慢性肝病患者的肌肉量下降。
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354. doi: 10.1002/jcsm.12392. Epub 2019 Feb 21.
4
Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.骨骼肌质量丢失与肝细胞癌死亡率及肿瘤复发之间的关联：一项系统评价与荟萃分析
Liver Cancer. 2018 Mar;7(1):90-103. doi: 10.1159/000484950. Epub 2017 Dec 9.
5
Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function.白蛋白-胆红素分级在日本46681例肝细胞癌患者全国性调查中的验证、潜力及预后评估：对肝功能进行更详细评估的必要性
Liver Cancer. 2017 Nov;6(4):325-336. doi: 10.1159/000479984. Epub 2017 Sep 22.
6
Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis.肝硬化患者肌肉减少症的预后价值：一项系统评价和荟萃分析。
PLoS One. 2017 Oct 24;12(10):e0186990. doi: 10.1371/journal.pone.0186990. eCollection 2017.
7
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.补充支链氨基酸及步行锻炼对预防肝硬化患者肌肉减少症的疗效
Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423. doi: 10.1097/MEG.0000000000000986.
8
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria.日本肝脏学会肝病相关肌少症指南（第 1 版）：肌少症评估标准制定工作组的推荐意见。
Hepatol Res. 2016 Sep;46(10):951-63. doi: 10.1111/hepr.12774.
9
Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.日本慢性肝病患者的肌肉减少症及两种类型的肌肉减少症前期状态
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):940-7. doi: 10.1097/MEG.0000000000000661.
10
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.白蛋白-胆红素分级对2584例日本肝细胞癌患者预后评估的价值
J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250.